GRDN

Analyst Sentiment

Wall St. Consensus
Buy
3 analysts·Low coverage
75
Score
3 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
3100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$36.00
-1.7%
Consensus
$38.00
+3.7%
Bull
$40.00
+9.2%
12-Month Target Range3 analysts
$36.00$38.00$40.00
Current $36.64Consensus
Current Price
$36.64
Upside to Consensus
$1.36

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+7.68%
EPS+10.07%
FY2028
Rev+10.58%
EPS+8.28%

Earnings Surprises

Recent Analyst Actions

Mar 12, 2026Raymond James
Guardian Pharmacy Services Inc. (GRDN) PT Raised to $40 at Raymond James
Target:$40.00
+20.2%from $33.27
Mar 12, 2026Truist Financial
Guardian Pharmacy Services Inc. (GRDN) PT Raised to $38 at Truist on 'Strong Close To '25'
Target:$38.00
+10.2%from $34.47
Jan 14, 2026Stephens
Guardian Pharmacy price target raised to $36 from $35 at Stephens
Target:$36.00
+15.2%from $31.26
Nov 14, 2025Truist Financial
Guardian Pharmacy price target raised to $34 from $30 at Truist
Target:$34.00
+15.2%from $29.51
Oct 10, 2025Oppenheimer
Guardian Pharmacy initiated with an Outperform at Oppenheimer
Target:$30.00
+26.7%from $23.68
Sep 26, 2025Truist Financial
Guardian Pharmacy price target raised to $30 from $28 at Truist
Target:$30.00
+16.8%from $25.68
May 14, 2025Raymond James
Guardian Pharmacy price target raised to $28 from $25 at Raymond James
Target:$28.00
+16.1%from $24.12